RxDoctor Payments Data

Spruha Magodia, DPM

Foot & Ankle Surgery · Lawrence Township, NJNPI 1124556865

Payments from drug & device makers

What this record shows

This record is dominated by other: $37,000 of the $39,413 with a category attached, or 93.9%. Convatec Inc. accounts for 93.9% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $37,447, more than ten times the $305 reported in 2021. Among foot & ankle surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,413in general payments, 2019–2025

Across 48 payments — averaging $821.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$37K
  • Stryker$1K
  • Nevro Corp.$597
  • Organogenesis Inc.$189
  • Smith+Nephew$155
  • Globus Medical$144
  • plus $285 from 6 others

What the payments were for

  • Food & beverage$2,4136%
  • Other$37,00094%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Convatec Inc.5$37,000
Stryker10$1,043
Nevro Corp.13$597
Organogenesis Inc.2$189
Smith+Nephew2$155
Globus Medical8$144
Carbofix Orthopedics Inc1$143
Paratek Pharmaceuticals, Inc.3$47
Bonalive Inc1$44
Liberty Surgical Inc.1$19
Triad Life Sciences Inc.1$18
Medtronic1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,413 in reported general payments places this provider in the 95th percentile of 542 foot & ankle surgery providers in New Jersey.

See all foot & ankle surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$464,403
Medicare patients
729
Services billed
6,860

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole28$21,838
Ketoconazole36$469
Silver Sulfadiazine12$53
Meloxicam28$32

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Lawrence Township

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →